We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+38%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$30.4B
AUM Growth
+$7.6B
(+33%)
Cap. Flow
+$167M
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
34%
Holding
622
New
73
Increased
196
Reduced
171
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$401M |
| 2 |
Shake Shack
SHAK
|
+$141M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$121M |
| 4 |
Datadog
DDOG
|
+$98.1M |
| 5 |
Lowe's Companies
LOW
|
+$92.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$184M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$143M |
| 3 |
NVIDIA
NVDA
|
+$136M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$130M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$106M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.43% |
| 2 | Healthcare | 21.84% |
| 3 | Consumer Discretionary | 15% |
| 4 | Communication Services | 9.98% |
| 5 | Financials | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Amgen
AMGN
$209B
| $1.46M | ﹤0.01% |
6,172
+63
| +1% | +$14.4K |
|
327
AT&T
T
$164B
| $1.45M | ﹤0.01% |
63,388
| – | – |
|
328
Adaptive Biotechnologies
ADPT
$3.61B
| $1.36M | ﹤0.01% |
28,171
+8,000
| +40% | +$292K |
|
329
InMode
INMD
$871M
| $1.33M | ﹤0.01% |
94,296
+10,176
| +12% | +$136K |
|
330
ExxonMobil
XOM
$650B
| $1.33M | ﹤0.01% |
29,849
| – | – |
|
|
EB
331
DELISTED
Eventbrite
EB
| $1.29M | ﹤0.01% |
+150,926
| New | +$1.33M |
|
332
McDonald's
MCD
$193B
| $1.27M | ﹤0.01% |
6,896
+68
| +1% | +$12.5K |
|
333
Eaton
ETN
$141B
| $1.24M | ﹤0.01% |
14,179
+4
| +0% | +$329 |
|
334
Akebia Therapeutics
AKBA
$338M
| $1.22M | ﹤0.01% |
90,000
+35,000
| +64% | +$362K |
|
335
GSK
GSK
$107B
| $1.2M | ﹤0.01% |
23,466
| – | – |
|
336
Edwards Lifesciences
EW
$49.4B
| $1.18M | ﹤0.01% |
17,095
-15,062
| -47% | -$1.07M |
|
337
Ocular Therapeutix
OCUL
$1.83B
| $1.17M | ﹤0.01% |
140,000
+105,000
| +300% | +$696K |
|
338
Sempra
SRE
$58.1B
| $1.16M | ﹤0.01% |
19,822
| – | – |
|
|
SPLK
339
DELISTED
Splunk Inc
SPLK
| $1.16M | ﹤0.01% |
+5,826
| New | +$921K |
|
|
XLRN
340
DELISTED
Acceleron Pharma
XLRN
| $1.14M | ﹤0.01% |
12,000
+2,000
| +20% | +$193K |
|
341
Fate Therapeutics
FATE
$275M
| $1.14M | ﹤0.01% |
33,166
+5,166
| +18% | +$154K |
|
342
Equinix
EQIX
$99.4B
| $1.1M | ﹤0.01% |
1,567
| – | – |
|
343
Chevron
CVX
$382B
| $1.1M | ﹤0.01% |
12,331
-25
| -0.2% | -$2.24K |
|
344
ConocoPhillips
COP
$144B
| $1.1M | ﹤0.01% |
26,121
| – | – |
|
345
Chefs' Warehouse
CHEF
$4.31B
| $1.09M | ﹤0.01% |
+79,981
| New | +$1.1M |
|
346
Medtronic
MDT
$112B
| $1.08M | ﹤0.01% |
11,803
| – | – |
|
|
CONE
347
DELISTED
CyrusOne Inc Common Stock
CONE
| $1.07M | ﹤0.01% |
14,754
-87
| -0.6% | -$6.2K |
|
348
Lamar Advertising Co
LAMR
$16.7B
| $1.07M | ﹤0.01% |
16,046
| – | – |
|
|
NVTA
349
DELISTED
Invitae Corporation
NVTA
| $1.06M | ﹤0.01% |
+35,000
| New | +$611K |
|
350
Americold
COLD
$4.21B
| $1.06M | ﹤0.01% |
29,131
-76,731
| -72% | -$2.62M |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q2 2020 Portfolio in Review
As of Q2 2020, Fred Alger Management held 622 positions worth $30.4B, up 33% from $22.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Fred Alger Management's Q2 2020 filing shows 73 new, 196 increased, 171 reduced and 128 closed positions. Its largest new stake was Datadog: 1,611,567 shares worth $140M. The largest sale was Microsoft, an estimated $184M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fred Alger Management's largest Q2 2020 buy was Datadog: 1,611,567 shares worth $140M.
- Fred Alger Management added most to T-Mobile US in Q2 2020, an estimated $401M increase.
- Fred Alger Management's biggest Q2 2020 reduction was Microsoft, cutting an estimated $184M.
- Fred Alger Management fully exited Raytheon Company in Q2 2020, selling an estimated $46M.
- Fred Alger Management's ten largest holdings make up 34% of its $30.4B portfolio in Q2 2020.
- Fred Alger Management opened 73 new positions and closed 128 in Q2 2020.
- Fred Alger Management's portfolio value rose 33% quarter-over-quarter to $30.4B.
Based on Fred Alger Management's 13F filing for Q2 2020, filed 14 Aug 2020.